Research To Practice | Oncology Videos

Latest Episodes:

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer Feb 21, 2023

Show notes

Featuring perspectives from Dr Bob Li, including the following topics:

• Evolution of targeted therapy for HER2-altered non-small cell lung cancer (NSCLC) (0:00)

• Incidence and management of HER2 amplifications and mutations in NSCLC (10:45)

• Role of ErbB/HER protein family biology in lung cancer (19:03)

• Current and emerging roles of antibody-drug conjugates in lung cancer (33:43)

• Considerations for clinical trial participation and improving access to care for patients with cancer (55:08)

• Management of trastuzumab deruxtecan-associated interstitial lung disease (1:03:18)

• Future of HER2-targeted therapy in lung cancer and beyond (1:14:39)

CME information and select publications

Hodgkin and Non-Hodgkin Lymphomas | Laurie H Sehn, MD, MPH Feb 18, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas — Faculty Presentation 2: Follicular Lymphoma and Mantle Cell Lymphoma — Dr Laurie Sehn

CME information and select publications

Hodgkin and Non-Hodgkin Lymphomas | Christopher R Flowers, MD, MS Feb 18, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas — Faculty Presentation 1: Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Dr Christopher Flowers

CME information and select publications

Hodgkin and Non-Hodgkin Lymphomas | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas Feb 18, 2023

Show notes

Featuring perspectives from Drs Christopher Flowers and Laurie Sehn, including the following topics:

• Introduction (0:00)

• Treatment for Diffuse Large B-Cell Lymphoma (7:45)

• Management of Hodgkin Lymphoma (35:33)

• Follicular Lymphoma (41:57)

• Caring for Patients with Mantle Cell Lymphoma (51:38)

CME information and select publications

Thyroid Cancer and Neuroendocrine Tumors | Oncology Today with Dr Neil Love — Thyroid Cancer and Neuroendocrine Tumors Feb 15, 2023

Show notes

Featuring perspectives from Drs Jonathan Strosberg and Lori Wirth, including the following topics:

Nontargeted Treatment for Thyroid Cancer
- Introduction (0:00)
- Case: A woman in her late 60s with poorly differentiated thyroid cancer initially treated with lenvatinib – Dr Wirth (6:05)
NTRK Fusions in Thyroid Cancer
- Case: A woman in her early 60s with metastatic papillary thyroid cancer with an NTRK fusion who received repotrectinib – Eric Sherman, MD (13:27)
- Case: A man in his early 60s with metastatic papillary thyroid cancer with NTRK fusion who received larotrectinib – Dr Wirth (18:37)
RET Mutations/Fusions in Thyroid Cancer
- Case: A man in his early 40s who presents with metastatic medullary thyroid cancer with a RET mutation – Dr Sherman (21:43)
- Case: A man in his early 40s with metastatic medullary thyroid cancer with a RET mutation who received selpercatnib – Dr Wirth (27:49)
Somatostatin Analogs for Neuroendocrine Tumors (NETs)
- Case: A woman in her early 50s with a newly well-differentiated small-bowel NET and low-volume liver metastases – Pamela Kunz, MD (33:41)
Management of Carcinoid Syndrome with NETs
- Cases: A man in his early 60s with a well-differentiated small-bowel NET with stable disease on octreotide who is now experiencing increasing diarrhea and a man in his early 60s who received telotristat ethyl for carcinoid syndrome diarrhea – Dr Kunz and Dr Strosberg (41:25)
Von Hippel-Lindau-Associated Pancreatic NETs
- Case: A woman in her late 40s with von Hippel-Lindau syndrome and a pancreatic NET who received belzutifan – Dr Strosberg (49:42)
- Case: A man in his early 60s with a symptomatic, well-differentiated hypervascular pancreatic NET with bulky liver metastases – Dr Kunz (55:38)

CME information and select publications

Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 Feb 14, 2023

Show notes

Featuring perspectives from Dr Noopur Raje, including the following topics:

• Introduction (0:00)

• Case: A man in his early 80s who presents with renal failure (creatine = 7) and standard-risk multiple myeloma (MM) — Swati Vishwanathan, MD (14:22)

• Case: A man in his late 60s with a large sternal plasmacytoma — Warren S Brenner, MD (20:35)

• Case: A man in his early 60s who presents with multiple bone lesions and t(4;14), (1q21+) MM — Hans Lee, MD (23:21)

• Case: A man in his late 30s with standard-risk MM who receives RVd followed by autologous stem cell transplant and has been on maintenance lenalidomide for 3.5 years — Yanjun Ma, MD (32:32)

• Case: An asymptomatic woman in her mid 60s with quadruple-refractory MM with multiple prior serious infections — Neil Morganstein, MD (40:38)

• Faculty Survey (53:19)

• Case: A woman in her mid 70s with MM who developed severe peripheral neuropathy from induction RVd — Ranju Gupta, MD (57:45)

CME information and select publications

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture) Feb 13, 2023

Show notes

Featuring a slide presentation and related discussion from Dr Edward Garon, including the following topics:

• Immune checkpoint inhibitor therapy for treatment-naïve advanced non-small cell lung cancer (NSCLC) without an actionable mutation (0:00)

• Duration of immunotherapy in the frontline setting for NSCLC with no targetable mutation (13:43)

• New treatment strategies for relapsed or refractory NSCLC with no targetable mutation (16:25)

• Management of antibody-drug conjugate-associated toxicity (19:08)

• Activity of antibody-drug conjugates alone or in combination with anti-PD-1 antibodies (26:18)

CME information and select publications

Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation Feb 13, 2023

Show notes

Featuring an interview with Dr Edward Garon, including the following topics:

Treatment of non-small cell lung cancer (NSCLC) today versus prior to the availability of immune checkpoint inhibitors (0:00)
Current and emerging roles of antibody-drug conjugates in NSCLC (3:30)
Optimal workup for patients presenting with metastatic NSCLC; role of biomarker assessment (5:02)
Considerations for the addition of an anti-CTLA-4 antibody to the treatment regimen for NSCLC (17:30)
Correlation between immune-related toxicity and the efficacy of immune checkpoint inhibitors (21:47)
Case: A woman in her mid 60s with multiple comorbidities presenting with NSCLC with a KRAS G12A mutation, pleural effusion and extensive bone metastases (24:35)
Case: A man in his mid 50s with a long smoking history presenting with squamous cell carcinoma of the lung (31:07)
Case: A woman in her early 60s with NSCLC with an EGFR L858R mutation who is relapsing after treatment with multiple therapies (37:22)
Language barriers leading to disparities in clinical trial enrollment (44:38)

CME information and select publications

Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting Feb 09, 2023

Show notes

Featuring perspectives from Dr Srdan Verstovsek, including the following topics:

Overview of current issues in the management of myeloproliferative neoplasms (MPN) (0:00)
Treatment strategies for patients with myelofibrosis (MF) progressing after ruxolitinib (14:46)
Correlation of molecular characterization and response to ruxolitinib in patients with MF (23:57)
Rationale for and efficacy with combined inhibition of Bcl-2 and Bcl-xL for MPN (44:38)
Targeting calreticulin mutations for MPN (52:02)
Advances in the management of polycythemia vera (57:54)
Developments in the care of patients with essential thrombocythemia (1:04:43)
Future directions in the clinical care of patients with MPN (1:12:46)

CME information and select publications

Gynecologic Oncology | Krishnansu S Tewari, MD Feb 08, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology — Faculty Presentation 2: Endometrial and Cervical Cancer — Dr Krishnansu Tewari

CME information and select publications

Our TOPPODCAST Picks

Follow Us

Stay Connected

Research To Practice | Oncology Videos

Related Podcasts

Links

Stay Connected